An interventional study of laparoscopic common bile duct exploration and laparoscopic cholecystectomy and intraoperative endoscopic sphincterotomy in Common Bile Duct Gallstones, sponsored by Mansoura University. Completed at 1 site in Egypt. Open to participants aged 12 Years to 90 Years. Per ClinicalTrials.gov, last updated 2010-08-27.
Sponsored by Mansoura University · Not applicable, Interventional, and Treatment
Many options are available for management of common bile duct stones. the most recent development in this field is single-session approach by one of two methods; laparoscopic common bile duct exploration and intraoperative endoscopic sphincterotomy. In this study, the investigators prospectively compare these two methods for management of patients with preoperatively diagnosed common bile duct stones to settle the best option.
346 studies on the registry are indexed under Gallstones; 46 are open to participants now.
This study's enrollment of 248 is above the median of 99 across 232 interventional studies indexed under Gallstones.
Browse Gallstones studies →Mansoura University is the lead sponsor of 1,077 studies on the registry; 183 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Procedure: laparoscopic common bile duct exploration
Procedure: laparoscopic cholecystectomy and intraoperative endoscopic sphincterotomy
success/failure of common bile duct removal
Surgical time
This study is completed, as verified in Feb 2010. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Mansoura University